THE ARISING · DAILY EDITION
The Arising — October 16, 2026
Download the PDF ↓Longevity & Healthspan
Yale Study: Single-Clock Biological Age Reversal Claims Failed Multi-Clock Checks
A claim that a diet or supplement "reversed biological age" may rest on a single test reading, and a new analysis suggests that is often not enough to trust. The study re-examined only three published singleclock results, so it does not show that most such claims fail. It shows that those three did not hold up across a wider panel of clocks.
Reading medical evidence →Merck and Moderna Plan Wider Tests of Personalized mRNA Cancer Vaccine
A vaccine made from a patient's own tumor may soon be offered to people with melanoma to keep the cancer from coming back after surgery, and the companies behind it now want to test it in other cancers.
Reading medical evidence →35-Year Study Links Cannabis Use to More Fragmented Sleep in Midlife
Cannabis is often promoted as a sleep aid, but a long-running study suggests it may be linked to poorer sleep in midlife, and people who use it may not notice.
Sleep →Ovaries Keep Changing for Decades After Menopause, Northwestern-Buck Study Finds
The ovary does not go quiet after menopause. A new study in Aging Cell finds that its protein makeup keeps shifting for decades, toward more inflammation and tissue remodeling.
Longevity in daily life →Large NIH Study Finds No Overall Ultra-Processed Food Link to Colorectal Cancer
People who ate the most ultra-processed food were no more likely to develop colorectal cancer than people who ate the least, according to a large US study published in PLOS Medicine in 2026. The study followed participants from 1995–96 through 2018.
Longevity in daily life →
Markets & Strategy
HHS Sends Peptide Compounding Policy to White House for Review
A federal plan to let pharmacies compound unapproved peptide injections has moved to the White House for review. Wall Street analysts estimate the peptide market could be worth $2 billion to $3 billion, though the source does not say how much of it this plan would open.
Care and connection →GlobalData Forecasts Alzheimer's Drug Sales Rising Sixfold to $14.7 Billion by 2033
Alzheimer's drug sales in eight major markets could grow from $2.4 billion in 2023 to $14.7 billion by 2033, according to a GlobalData forecast reported by Longevity.Technology. That is about a sixfold increase.
Brain health →Bank of America: Retirements Among Workers Over 55 Drive Falling Labor Participation
Stock market gains may be doing something to the U.S. labor force that few employers planned for: helping older workers leave it.
Longevity in daily life →Function Health Lets Members Share Lab Results With Google Health App
Function Health, a lab-testing company that sells itself on longevity, will let US members send their blood test results into the Google Health app, putting them next to the daily data from a Fitbit or Pixel Watch. The results go into the app, not into the wearables themselves.
Reading medical evidence →Massachusetts Approves Nursing Home Rules Scrutinizing Owners, Management Firms and Private Equity
Massachusetts is giving health regulators new power to ask who owns and manages a nursing home, and whether they should be running it at all.
Care and connection →